Výsledky vyhledávání - "Paul C. Cockrum"

Akademický článek

Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits

Autor: John D. Sheppard, Paul C. Cockrum, Angela Justice, Mark C. Jasek

Publikováno v: Ophthalmology and Therapy, Vol 8, Iss 2, Pp 347-348 (2019)

In the original publication, units were incorrectly published in the results section as micrograms (µg/mL).

Externí odkaz: https://doaj.org/article/e5be4339f2484bf490435ab502f92d90

Zobrazit plný text záznamu

Plný text ve formátu HTML

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits

Autor: Mark C. Jasek, Angela Justice, Paul C. Cockrum, John D. Sheppard

Publikováno v: Ophthalmology and Therapy

Introduction Little is known of the ocular distribution characteristics of currently branded non-steroidal anti-inflammatory drugs (NSAIDs) in the United States. This study was designed to predict the ocular bioavailability characteristics in humans

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f58466d7e25909628ccde0dfe0bc4f
http://europepmc.org/articles/PMC5997598

Zobrazit plný text záznamu

Plný text ve formátu HTML

A Pharmacoeconomic Analysis of Patients with Symptoms of Benign Prostatic Hyperplasia

Autor: Steven F. Finder, Roger P. Potyk, Andrea J. Ries, Paul C. Cockrum

Publikováno v: PharmacoEconomics. 11:550-565

A pharmacoeconomic analysis of therapies for patients with benign prostatic hyperplasia (BPH) was conducted. The therapies compared were androgenic hormone inhibition (finasteride) and alpha-blockade (doxazosin, prazosin and terazosin). This was a co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::762f9d74535a997865c726ab6690fe12
https://doi.org/10.2165/00019053-199711060-00004

Zobrazit plný text záznamu

Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients : prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study

Autor: Margaret Kennedy, Dina Amin, Anna Whitling, Ricardo Notivol, Paul C. Cockrum, David Wells

Publikováno v: Clinical drug investigation. 24(9)

To demonstrate the superiority of TobraDex((R)) (tobramycin 3 mg/mL, dexamethasone 1 mg/mL) eye drops over Tobrex((R)) (tobramycin 3 mg/mL)/vehicle (placebo) eye drops in the prophylaxis of inflammation after cataract surgery, and to provide addition

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab62949530c1e517f0ce4c8c79d88822
https://pubmed.ncbi.nlm.nih.gov/17523714

Zobrazit plný text záznamu

A critical review of published economic modelling studies in depression

Autor: Michael T. Jones, Paul C. Cockrum

Publikováno v: PharmacoEconomics. 17(6)

Depression is a very costly chronic disease. An important cost driver is treatment failure caused by patient noncompliance due, in part, to the adverse effects of medications. Additionally, inadequate duration of therapy and inappropriate medication

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f09749ce3e569a4ebd73642cf2ad9c
https://pubmed.ncbi.nlm.nih.gov/10977394

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání